author-photo

Shelledy L

1

Papers

16

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma.

2015 Journal of the advanced practitioner in oncology
- Shelledy L
- Roman D
Show All
- Source
- Cite
- Save
Citations (16)